-
Je něco špatně v tomto záznamu ?
Formyl peptide receptor 2 regulates dendritic cell metabolism and Th17 cell differentiation during neuroinflammation
JH. Lim, A. Neuwirth, KJ. Chung, S. Grossklaus, O. Soehnlein, G. Hajishengallis, T. Chavakis
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
R01 DE029436
NIDCR NIH HHS - United States
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- MeSH
- buněčná diferenciace * MeSH
- buňky Th17 * imunologie metabolismus MeSH
- cytokiny metabolismus MeSH
- dendritické buňky * imunologie metabolismus MeSH
- encefalomyelitida autoimunitní experimentální * imunologie metabolismus MeSH
- mícha imunologie metabolismus MeSH
- myši inbrední C57BL MeSH
- myši knockoutované * MeSH
- myši MeSH
- neurozánětlivé nemoci imunologie metabolismus MeSH
- receptory pro formylované peptidy * genetika metabolismus MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Formyl peptide receptor 2 (FPR2) is a receptor for formylated peptides and specific pro-resolving mediators, and is involved in various inflammatory processes. Here, we aimed to elucidate the role of FPR2 in dendritic cell (DC) function and autoimmunity-related central nervous system (CNS) inflammation by using the experimental autoimmune encephalomyelitis (EAE) model. EAE induction was accompanied by increased Fpr2 mRNA expression in the spinal cord. FPR2-deficient (Fpr2KO) mice displayed delayed onset of EAE compared to wild-type (WT) mice, associated with reduced frequencies of Th17 cells in the inflamed spinal cord at the early stage of the disease. However, FPR2 deficiency did not affect EAE severity after the disease reached its peak. FPR2 deficiency in mature DCs resulted in decreased expression of Th17 polarizing cytokines IL6, IL23p19, IL1β, and thereby diminished the DC-mediated activation of Th17 cell differentiation. LPS-activated FPR2-deficient DCs showed upregulated Nos2 expression and nitric oxide (NO) production, as well as reduced oxygen consumption rate and impaired mitochondrial function, including decreased mitochondrial superoxide levels, lower mitochondrial membrane potential and diminished expression of genes related to the tricarboxylic acid cycle and genes related to the electron transport chain, as compared to WT DCs. Treatment with a NO inhibitor reversed the reduced Th17 cell differentiation in the presence of FPR2-deficient DCs. Together, by regulating DC metabolism, FPR2 enhances the production of DC-derived Th17-polarizing cytokines and hence Th17 cell differentiation in the context of neuroinflammation.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019433
- 003
- CZ-PrNML
- 005
- 20241024110717.0
- 007
- ta
- 008
- 241015e20240801sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fimmu.2024.1354074 $2 doi
- 035 __
- $a (PubMed)39148732
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Lim, Jong-Hyung $u Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States $u Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
- 245 10
- $a Formyl peptide receptor 2 regulates dendritic cell metabolism and Th17 cell differentiation during neuroinflammation / $c JH. Lim, A. Neuwirth, KJ. Chung, S. Grossklaus, O. Soehnlein, G. Hajishengallis, T. Chavakis
- 520 9_
- $a Formyl peptide receptor 2 (FPR2) is a receptor for formylated peptides and specific pro-resolving mediators, and is involved in various inflammatory processes. Here, we aimed to elucidate the role of FPR2 in dendritic cell (DC) function and autoimmunity-related central nervous system (CNS) inflammation by using the experimental autoimmune encephalomyelitis (EAE) model. EAE induction was accompanied by increased Fpr2 mRNA expression in the spinal cord. FPR2-deficient (Fpr2KO) mice displayed delayed onset of EAE compared to wild-type (WT) mice, associated with reduced frequencies of Th17 cells in the inflamed spinal cord at the early stage of the disease. However, FPR2 deficiency did not affect EAE severity after the disease reached its peak. FPR2 deficiency in mature DCs resulted in decreased expression of Th17 polarizing cytokines IL6, IL23p19, IL1β, and thereby diminished the DC-mediated activation of Th17 cell differentiation. LPS-activated FPR2-deficient DCs showed upregulated Nos2 expression and nitric oxide (NO) production, as well as reduced oxygen consumption rate and impaired mitochondrial function, including decreased mitochondrial superoxide levels, lower mitochondrial membrane potential and diminished expression of genes related to the tricarboxylic acid cycle and genes related to the electron transport chain, as compared to WT DCs. Treatment with a NO inhibitor reversed the reduced Th17 cell differentiation in the presence of FPR2-deficient DCs. Together, by regulating DC metabolism, FPR2 enhances the production of DC-derived Th17-polarizing cytokines and hence Th17 cell differentiation in the context of neuroinflammation.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a dendritické buňky $x imunologie $x metabolismus $7 D003713
- 650 12
- $a receptory pro formylované peptidy $x genetika $x metabolismus $7 D044042
- 650 12
- $a buňky Th17 $x imunologie $x metabolismus $7 D058504
- 650 _2
- $a myši $7 D051379
- 650 12
- $a encefalomyelitida autoimunitní experimentální $x imunologie $x metabolismus $7 D004681
- 650 12
- $a buněčná diferenciace $7 D002454
- 650 12
- $a myši knockoutované $7 D018345
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a neurozánětlivé nemoci $x imunologie $x metabolismus $7 D000090862
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mícha $x imunologie $x metabolismus $7 D013116
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Neuwirth, Ales $u Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany $u Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Chung, Kyoung-Jin $u Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
- 700 1_
- $a Grossklaus, Sylvia $u Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
- 700 1_
- $a Soehnlein, Oliver $u Institute for Experimental Pathology, Center for Molecular Biology of Inflammation, University of Münster, Münster, Germany
- 700 1_
- $a Hajishengallis, George $u Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States
- 700 1_
- $a Chavakis, Triantafyllos $u Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
- 773 0_
- $w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 15 (20240801), s. 1354074
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39148732 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024110711 $b ABA008
- 999 __
- $a ok $b bmc $g 2201958 $s 1231406
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 15 $c - $d 1354074 $e 20240801 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
- GRA __
- $a R01 DE029436 $p NIDCR NIH HHS $2 United States
- LZP __
- $a Pubmed-20241015